Patents by Inventor Bernard Bailleul

Bernard Bailleul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LEPROTL1 and OB-RGRP genes for screening compounds that act on the gain or loss of weight or on diabetes in a human or animal subject
    Publication number: 20060068429
    Abstract: A method for identifying compounds acting on weight gain or weight loss or on diabetes in a human or animal subject including measuring effect of the compounds on (a) expression of at least one of genes LEPROTL1 and OB-RGRP or a part of them and/or (b) intracellular transport up to a cellular membrane and/or (c) presence at the cellular membrane level and/or (d) internalization from the membrane of proteins coded by at least one of these genes or part of them.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 30, 2006
    Applicant: Centre National de la Recherche Scientifique - CNRS, an organization of France
    Inventors: Bernard Bailleul, Yves Rouille, Karin Seron, Sandrine Belouzard
  • Novel human leptin receptor gene-related protein
    Publication number: 20030166847
    Abstract: The present invention provides a polynucleotide which identifies and encodes a novel human leptin receptor gene-related protein (LRGRP). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding LRGRP. The invention also provides for the use of substantially purified LRGRP and its agonists, antagonists, or inhibitors in the commercial production of recombinant proteins and in pharmaceutical compositions for the treatment of diseases associated with the expression of LRGRP. Additionally, the invention provides for the use of antisense molecules to LRGRP in pharmaceutical compositions for treatment of diseases associated with the expression of LRGRP.
    Type: Application
    Filed: November 5, 2001
    Publication date: September 4, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Bernard Bailleul, A. Donny Strosberg, Ingrid E. Akerblom
  • Human leptin receptor gene-related protein
    Patent number: 5874535
    Abstract: The present invention provides a polynucleotide which identifies and encodes a novel human leptin receptor gene-related protein (LRGRP). The invention also provides expression vectors, host cells, agonists, and antagonists. The invention also provides methods for treating metabolic, reproductive, connective tissue and reproductive disorders.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: February 23, 1999
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Bernard Bailleul, A. Donny Strosberg, Ingrid E. Akerblom